ARCHIVES

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

This article is from The Cancer Letter archive.

Vol. 25 No. 05 | February 5, 1999

Download PDF Visit The Full Archive

Related Articles

In Brief: Barry Pierce New DCCP Chairman; Adamson Seeks Ads For Chemical, Biological Carcinogenesis

June 17, 1983

Late Effects In Breast Cancer Treatment Found In Study

January 25, 2002

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977

NCI Awards $59M Contract For Key Project To consolidate Phase III Trial Administration

October 29, 1999

Studies Link Age-Dependent Outcome To Immune Cells

November 28, 2003

DFCI Puts The Cancer Letter On Its Intranet For Employees.

February 11, 2000